Search results for “Cephamycin C” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 190 patents, we discovered top 41 key players by total patent application. Merck & Co., Inc., Eli Lilly & Co., Glaxo Laboratories Ltd. are dominant in this area. They take 29.47% of the total patent filing.
Merck & Co., Inc.
New Jersey, United States
Patent: 27
Eli Lilly & Co.
Indiana, United States
Patent: 17
Glaxo Laboratories Ltd.
United Kingdom
Patent: 12
Takeda Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 11
Sankyo Co., Ltd.
Tokyo-to, Japan
Patent: 11
Biochemie GmbH
Tirol, Austria
Patent: 10
National Research Development Corp.
United Kingdom
Patent: 9
Bioferma Murcia SA
Murcia, Spain
Patent: 9
Nippon Kayaku Co., Ltd.
Tokyo-to, Japan
Patent: 8
Otsuka Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 6
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 7 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Shanghai Institute of Pharmaceutical Industry
Shanghai Shi, China
Patent: 4
University of Minnesota
Minnesota, United States
Patent: 2
Osmania University
Andhra Pradesh, India
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: